BIOMAT Database Logo BIOMAT Database Logo

Residual pancreatic beta-cell function in insulin-dependent diabetes mellitus. 1987

S Amemiya, and K Higashida, and M Fujimoto, and K Asayama, and K Ichimura, and S Kusano, and K Ohyama, and K Kato

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D014044 Tolbutamide A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Apo-Tolbutamide,Artosin,Diabetol,Diaval,Dolipol,Orabet,Orinase,Rastinon,Tolbutamid R.A.N.

Related Publications

S Amemiya, and K Higashida, and M Fujimoto, and K Asayama, and K Ichimura, and S Kusano, and K Ohyama, and K Kato
Residual beta-cell function and metabolic stability in insulin-dependent diabetes mellitus.
May 1988, The Tohoku journal of experimental medicine,
S Amemiya, and K Higashida, and M Fujimoto, and K Asayama, and K Ichimura, and S Kusano, and K Ohyama, and K Kato
Exocrine pancreatic function in insulin-dependent diabetes mellitus.
January 1982, Digestion,
S Amemiya, and K Higashida, and M Fujimoto, and K Asayama, and K Ichimura, and S Kusano, and K Ohyama, and K Kato
Residual insulin secretion in insulin dependent diabetes mellitus.
May 1986, Archives of disease in childhood,
S Amemiya, and K Higashida, and M Fujimoto, and K Asayama, and K Ichimura, and S Kusano, and K Ohyama, and K Kato
Residual insulin secretion in insulin dependent diabetes mellitus.
March 1985, Archives of disease in childhood,
S Amemiya, and K Higashida, and M Fujimoto, and K Asayama, and K Ichimura, and S Kusano, and K Ohyama, and K Kato
Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus.
January 1987, Diabetes care,
S Amemiya, and K Higashida, and M Fujimoto, and K Asayama, and K Ichimura, and S Kusano, and K Ohyama, and K Kato
Effect of gliclazide on plasma lipids and pancreatic beta cell function in non-insulin-dependent diabetes mellitus.
December 1993, Changgeng yi xue za zhi,
S Amemiya, and K Higashida, and M Fujimoto, and K Asayama, and K Ichimura, and S Kusano, and K Ohyama, and K Kato
[Complex evaluation of pancreatic function in insulin-dependent diabetes mellitus].
January 1986, Meditsinskaia radiologiia,
S Amemiya, and K Higashida, and M Fujimoto, and K Asayama, and K Ichimura, and S Kusano, and K Ohyama, and K Kato
[Autoimmune aspects of insulin-dependent diabetes mellitus. Insulitis and pancreatic beta-cell destruction].
January 1986, Problemy endokrinologii,
S Amemiya, and K Higashida, and M Fujimoto, and K Asayama, and K Ichimura, and S Kusano, and K Ohyama, and K Kato
Beta-cell replacement for insulin-dependent diabetes mellitus.
January 2008, Advanced drug delivery reviews,
S Amemiya, and K Higashida, and M Fujimoto, and K Asayama, and K Ichimura, and S Kusano, and K Ohyama, and K Kato
Residual pancreatic function in insulin dependent diabetics.
February 1982, Australian and New Zealand journal of medicine,
Copied contents to your clipboard!